Mankind Pharma to host Q1FY27 earnings call on July 30

Mankind Pharma will host an investor conference call on July 30, 2026, at 06:30 PM IST to discuss its business performance and results for Q1FY27. The meeting provides an opportunity for investors to gain insights into the company's quarterly financial outcomes directly from its senior leadership team. The announcement was made pursuant to Regulation 30 & 51 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The conference call will be conducted via Zoom, requiring participants to register in advance to attend the session.

Earnings Call Schedule

Detail	Information
Date	Thursday, 30 July 2026
Time	06:30 PM – 07:30 PM IST
Platform	Zoom Webinar
Registration Link	https://us06web.zoom.us/webinar/register/WN_gjCF6TrYR9eK24zP-RYSZQ

Management Representation

The discussion will be led by key members of the company's executive team:

Mr. Rajeev Juneja – Vice Chairman & Managing Director
Mr. Sheetal Arora – Chief Executive Officer & Whole Time Director
Mr. Arjun Juneja – Chief Operating Officer
Mr. Sudipta Roy – Senior President – Sales & Marketing
Mr. Ashutosh Dhawan – Global Chief Financial Officer
Mr. Prakash Agarwal – President (Strategy)

Investors seeking further details or assistance regarding the conference call can reach out to Prakash Agarwal of Mankind Pharma Limited or the representatives at Adfactors PR.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+1.77%	+2.71%	+2.76%	+21.84%	-1.46%	+79.40%

Mankind Pharma Limited has approved the divestment of its entire 100% stake in Broadway Hospitality Services Private Limited for a total consideration of ₹49.00 Cr. The sale to AKRK Projects LLP and Partners is part of the company's strategy to exit non-core assets and is expected to be completed within 90 days. The transaction does not fall within related party transactions, and the buyers are not part of the promoter group. The board, which met on July 11, 2026, also authorized the execution of the Share Purchase Agreement.

Financials of Broadway Hospitality Services

Broadway Hospitality Services reported a turnover of ₹9.63 Cr and a net worth of ₹38.99 Cr as of March 31, 2026, contributing marginally to Mankind Pharma's overall financials. The table below provides a breakdown of the subsidiary's financial contribution.

Particulars	Amount (₹ Crores)	% Contribution to Company's Financials
Turnover / Revenue	9.63	0.07
Total Income	9.90	0.07
Net Worth	38.99	0.24

Key Transaction Details

The divestment is structured as a clean exit from a non-core hospitality business. Key parameters of the transaction are outlined below.

Parameter	Details
Buyer	AKRK Projects LLP and Partners
Consideration	₹49.00 Cr (subject to closing adjustment)
Completion Timeline	Within 90 days
Related Party Transaction	No

Netherlands Subsidiary for R&D and Niche Therapies

Separately, the board approved the incorporation of a wholly owned subsidiary in the Netherlands to function as a Special Purpose Vehicle. This entity will hold investments in research and development assets and focus on business development activities for niche therapies. The proposed investment for this subsidiary is up to Euro 5 Million, to be infused in one or more tranches.

The new subsidiary will operate within the pharmaceutical industry, potentially through joint ventures or strategic acquisitions. The incorporation is subject to approvals under the Foreign Exchange Management Act and relevant regulations from the Reserve Bank of India and authorities in the Netherlands.